Tuesday, Feb 20, 2024 · SEC filings
What the smart money revealed on Feb 20
1,851 insider filings came in. We hid 113 planned (10b5-1) sellers and 1,518 people whose filings were routine, like grants and tax withholding.
3 insiders at Iovance Biotherapeutics (IOVA) bought $48.3M of stock
Roles: Director. Several insiders buying in the same few days is rare.
Prime Medicine (PRME) Director Robert Nelsen bought $20M
3.2M shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.
Gates Industrial (GTES) Director Neil Simpkins bought $12.2M
1M shares on the open market. Not a grant or an option exercise.
Agree Realty (ADC) Director John Rakolta Jr. bought $1.16M
20,430 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 6 checked quarters beat the typical stock 6 months later.
Gates Industrial (GTES) Director Fredrik Eliasson bought $499K
40,893 shares on the open market. Not a grant or an option exercise.
DoorDash (DASH) Director Andy Fang sold $15.6M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 81,938 shares directly.
UnitedHealth Group (UNH) CEO Brian Thompson sold $15.1M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 25,543 shares directly.
Penske Automotive Group (PAG) Director Greg Smith sold $240K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 33 more real buys
Show 141 more real sales
13F season
Holdings as of Dec 31, 2023 were due Feb 14
49 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Feb 14–20
Open-market buys by officers and directors, filed in the 7 days up to Feb 20.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.